5-(8-cyclopropylimidazo[1,2-b]pyridazin-6-yl)-1H-pyrimidine-2,4-dione;3-(trifluoromethyl)-1,2-benzoxazole
C21H15F3N6O3 — CID 157032794
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(8-cyclopropylimidazo[1,2-b]pyridazin-6-yl)-1H-pyrimidine-2,4-dione;3-(trifluoromethyl)-1,2-benzoxazole
5-(8-cyclopropylimidazo[1,2-b]pyridazin-6-yl)-1H-pyrimidine-2,4-dione;3-(trifluoromethyl)-1,2-benzoxazole (PubChem CID 157032794) has the molecular formula C21H15F3N6O3 and a molecular weight of 456.38 g/mol. Its IUPAC name is 5-(8-cyclopropylimidazo[1,2-b]pyridazin-6-yl)-1H-pyrimidine-2,4-dione;3-(trifluoromethyl)-1,2-benzoxazole.
Molecular Properties
| Compound Name | 5-(8-cyclopropylimidazo[1,2-b]pyridazin-6-yl)-1H-pyrimidine-2,4-dione;3-(trifluoromethyl)-1,2-benzoxazole |
|---|---|
| PubChem CID | 157032794 |
| Molecular Formula | C21H15F3N6O3 |
| Molecular Weight | 456.38 g/mol |
| Exact Mass | 456.12 |
| IUPAC Name | 5-(8-cyclopropylimidazo[1,2-b]pyridazin-6-yl)-1H-pyrimidine-2,4-dione;3-(trifluoromethyl)-1,2-benzoxazole |
| SMILES | FC(F)(F)c1noc2ccccc12.O=c1[nH]cc(-c2cc(C3CC3)c3nccn3n2)c(=O)[nH]1 |
| InChI | InChI=1S/C13H11N5O2.C8H4F3NO/c19-12-9(6-15-13(20)16-12)10-5-8(7-1-2-7)11-14-3-4-18(11)17-10;9-8(10,11)7-5-3-1-2-4-6(5)13-12-7/h3-7H,1-2H2,(H2,15,16,19,20);1-4H |
| InChIKey | IJBWRAQVIYYIGR-UHFFFAOYSA-N |
| XLogP | 3.50 |
| TPSA | 121.94 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.38 |
| LogP ≤ 5 | 3.50 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157032794 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.